Skip to main content
. 1997 May 27;94(11):5810–5813. doi: 10.1073/pnas.94.11.5810

Table 2.

Serum GH, IGF-I, and IGF-II in nude mice bearing Caki-I human kidney cancer cell line xenografts after treatment with GH-RH antagonist MZ-4-71

Treatment group GH, ng/ml IGF-I, ng/ml IGF-II, ng/ml
Control 1.90  ± 0.15 127.7  ± 10.7 25.1  ± 2.0
MZ-4-71 1.29  ± 0.06* 94.8  ± 7.9* 26.2  ± 3.4

Values are mean ± SEM; ∗, P < 0.05 vs. control